BPC-157 + TB-500 Australia

BPC-157 + TB-500 Australia. This is the recovery blend, the pairing usually called the Wolverine stack. Between them these two carry most of the soft tissue repair literature. The research reports faster healing and better strength recovery in tendon, ligament and muscle injuries, less scar tissue with better remodelling of what does form, a more intact gut lining, nerve repair, and new blood vessels growing into damaged tissue.

How it does it. They are paired because they approach repair from opposite ends. BPC-157 works on the signals that supply a repair site, switching on growth factor and blood vessel pathways. TB-500 works on the machinery, controlling the actin scaffolding a cell has to rearrange before it can migrate into damaged tissue. One handles the instruction, the other handles the movement.

The vial. Both components are independently HPLC-content-tested by Janoshik, and the certificate reports each peptide separately rather than as one combined figure. Supplied in 10 mg and 20 mg combined strength vials, dispatched from Australia, AUD pricing. Supplied strictly for in-vitro and laboratory research use only. Not for human or animal consumption, not a therapeutic good, not TGA-approved.

The blend is a formulation rather than a single chemical entity, so it carries no single CAS number or molecular weight — each component has its own identity. BPC-157 (a synthetic 15-residue pentadecapeptide, Body Protective Compound-157) and TB-500 (the research-peptide name for thymosin β-4, the 43-residue G-actin-sequestering peptide) are the two components.

BPC-157 is referenced across tendon, ligament, gastric-tissue and angiogenesis research; its reported nitric-oxide-system interaction and VEGFR2-associated angiogenic signalling are covered by Seiwerth and colleagues (Frontiers in Pharmacology, 2021), and the pro-angiogenic VEGFR2 mechanism was reported by Hsieh and colleagues (Journal of Molecular Medicine, 2017).

TB-500 / thymosin β-4 is referenced across actin-dynamics and tissue-repair research; its role as a regulator of actin polymerisation in living cells was shown by Sanders and colleagues (Proceedings of the National Academy of Sciences, 1992), and its broader regenerative biochemistry is reviewed by Goldstein and colleagues (Expert Opinion on Biological Therapy, 2012).

The pairing is the canonical "soft-tissue stack" in research literature: the two act on distinct pathways (growth-factor / nitric-oxide signalling versus actin dynamics) that converge on the tissue-repair research model. Researchers reference the literature for each peptide separately and use the co-lyophilised vial as a methodological convenience. See the BPC-157 and TB-500 standalone product pages for the individual compounds.

The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, therapeutic, performance, or human-use claim about this product or its components. Both components are supplied strictly for in-vitro and laboratory research use only — not therapeutic goods, not TGA-approved, not for human or animal consumption.

Reconstitute the co-lyophilised vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently rather than shaking. Typical research protocols target a 1–2 mg/mL working concentration of each component; the per-peptide content reported on the certificate of analysis is the canonical reference for the downstream concentration math.

Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificate of analysis published in the lab-reports library.

Shop bacteriostatic water

Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.

30-day returns on unused product in original packaging, with prior approval.